SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950144-00-015352
Filing Date
2000-12-29
Accepted
2000-12-29 00:00:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 NOVAVAX, INC. g66078sc13d.txt SC 13D 27235
2 CONVERTIBILE NOTE OF NOVAVAX, INC. g66078ex1.txt EX-1 29395
3 NOTE PURCHASE AGREEMENT g66078ex2.txt EX-2 69464
4 INVESTOR RIGHTS AGREEMENT g66078ex3.txt EX-3 85639
5 REGISTRATION RIGHTS AGREEMENT g66078ex4.txt EX-4 64433
  Complete submission text file 0000950144-00-015352.txt   278661
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48948 | Film No.: 799237
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filed by) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations